Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 83 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
Mi | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
30.09. | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 97 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
10.09. | Catheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in Croatia | 1.059 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
04.09. | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
28.08. | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
21.08. | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
18.08. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
18.08. | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
15.08. | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
15.08. | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 378 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen | |
15.08. | XFRA 4RM: AUSSETZUNG/SUSPENSION | 436 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCATHETER PR. NEW... ► Artikel lesen | |
15.08. | XFRA NEW INSTRUMENTS AVAILABLE ON 15.08.2025 | 224 | Xetra Newsboard | The following instruments on XETRA do have their first trading 15.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.08.2025
Aktien
1 US4560361028 Industrial Bank of Korea... ► Artikel lesen | |
14.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.08.2025 | 508 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 14.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.08.2025.ISIN NameCA87168M1068 SYNEX... ► Artikel lesen | |
14.08. | XFRA ISIN CHANGE | 389 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS74933X6094 Catheter Precision Inc. 14.08.2025 US74933X7084 Catheter Precision Inc. 15.08.2025 Tausch 19:1CA31816R1091 Firefox... ► Artikel lesen | |
14.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.08.2025 | 388 | Xetra Newsboard | Das Instrument PCU US84265V1052 SOUTHERN COPPER DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 14.08.2025 und ex Kapitalmassnahme am 15.08.2025 The instrument PCU US84265V1052 SOUTHERN COPPER... ► Artikel lesen | |
13.08. | Catheter Precision, Inc.: First LockeT Cases Completed in Germany | 165 | GlobeNewswire (Europe) | FORT MILL, S.C., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
11.08. | Catheter Precision, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
11.08. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
28.07. | Catheter Precision kündigt Aktienzusammenlegung im Verhältnis 1 zu 19 für August an | 2 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 47,640 | +0,91 % | Fresenius-Aktie: Ein unerkannter Top-Pick? | Die Fresenius-Aktie steht bei den wenigsten Anlegern im Fokus, doch tatsächlich könnte der DAX-Konzern ein echter Top-Pick sein - meinen zumindest die Investmentbanken Morgan Stanley und JP Morgan.... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 46,400 | -0,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
ECKERT & ZIEGLER | 16,910 | -1,57 % | Eckert & Ziegler-Aktie sorgt für Aufsehen - steht jetzt die große Wende bevor? | ||
BICO GROUP | 2,144 | +0,09 % | BICO Group AB: Maria Rankka appointed Board Chair of BICO Group AB | The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders' meeting. Maria... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,102 | -3,77 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
RESMED | 229,10 | -0,26 % | Fractus files patent infringement complaint against ResMed in the Southern District of California | Action seeks to protect Fractus' pioneering antenna inventions used in connected sleep apnea therapies/devices
BARCELONA, Spain, Oct. 13, 2025 /PRNewswire/ -- Fractus... ► Artikel lesen | |
CARDINAL HEALTH | 132,85 | -0,86 % | Cardinal Health's Q1 2026 Earnings: What to Expect | ||
ATOSSA THERAPEUTICS | 0,840 | 0,00 % | Atossa Therapeutics Inc: Atossa Appoints Mark Daniel, CPA, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness | 25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial... ► Artikel lesen | |
UNIDOC HEALTH | 0,127 | -2,46 % | UniDoc Health Corp.: UniDoc Announces Amended LIFE Offering | THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / October 17, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)... ► Artikel lesen | |
ZIMMER BIOMET | 87,02 | +2,64 % | Demystifying Zimmer Biomet Holdings: Insights From 7 Analyst Reviews | ||
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals | BOULDER, CO / ACCESS Newswire / October 14, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in developing and producing stabilized hypochlorous acid (HOCl) products based... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,316 | +13,67 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
VERU | 4,100 | -4,43 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
CYTOSORBENTS | 0,755 | -0,53 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
ONTRAK | 0,184 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 26.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.08.2025.ISIN NameAU0000006934 NEW... ► Artikel lesen |